BNP Paribas Financial Markets
EVLO

BNP Paribas Financial Markets’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

BNP Paribas Financial Markets’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-83
Closed -$301 – 4048
2023
Q1 		$301 Buy
83
+5
+6% +$77 ﹤0.01% 3745
2022
Q4 		$2.5K Buy
78
+46
+144% +$1.82K ﹤0.01% 3716
2022
Q3 		$1.35K Sell
32
-152
-83% -$6.95K ﹤0.01% 4393
2022
Q2 		$7.75K Buy
184
+38
+26% +$1.76K ﹤0.01% 3777
2022
Q1 		$9.92K Sell
146
-193
-57% -$16.1K ﹤0.01% 3803
2021
Q4 		$41.2K Buy
339
+54
+19% +$9.12K ﹤0.01% 3770
2021
Q3 		$40.1K Buy
285
+247
+650% +$48.9K ﹤0.01% 3563
2021
Q2 		$10.5K Sell
38
-94
-71% -$23.7K ﹤0.01% 3714
2021
Q1 		$28.1K Sell
132
-67
-34% -$18.5K ﹤0.01% 3709
2020
Q4 		$48.1K Sell
199
-34
-15% -$4.21K ﹤0.01% 3570
2020
Q3 		$24.5K Buy
233
+153
+191% +$13.9K ﹤0.01% 3760
2020
Q2 		$7.83K Sell
80
-131
-62% -$11.5K ﹤0.01% 3813
2020
Q1 		$15.8K Buy
211
+62
+42% +$5.9K ﹤0.01% 3959
2019
Q4 		$12.1K Buy
149
+34
+30% +$3.8K ﹤0.01% 4107
2019
Q3 		$14K Buy
115
+6
+6% +$825 ﹤0.01% 4085
2019
Q2 		$19.5K Sell
109
-39
-26% -$6.3K ﹤0.01% 3909
2019
Q1 		$23.7K Buy
148
+143
+2,860% +$28.3K ﹤0.01% 3854
2018
Q4 		$1.24K Sell
5
-4
-44% -$805 ﹤0.01% 3896
2018
Q3 		$2.13K Hold
9
– – ﹤0.01% 4250
2018
Q2 		$2.06K Buy
+9
New +$2.62K ﹤0.01% 4252

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BNP Paribas Financial Markets's EVLO Position: Q2 2023 in Review

BNP Paribas Financial Markets sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2023, closing a stake of 83 shares — an estimated $301 sold.

BNP Paribas Financial Markets first reported a position in EVLO in Q2 2018 and held it in 20 quarters. The position peaked at $48.1K in Q4 2020. 25 funds tracked by Wall St. Rank hold EVLO as of Q2 2023.

  • BNP Paribas Financial Markets reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 83 Evelo Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $301.
  • BNP Paribas Financial Markets first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 20 quarters.
  • BNP Paribas Financial Markets's Evelo Biosciences, Inc. Common Stock position peaked at $48.1K in Q4 2020.
  • 25 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.